Elevated antiangiogenic factors predict preeclampsia in pregnant patients with SLE and/or APL antibodies

被引：0

作者：

Salmon, Jane E. ^{[1
]}

Guerra, Marta ^{[1
]}

Kim, Mimi ^{[2
]}

Rana, Sarosh ^{[3
]}

Karumanchi, S. Ananth ^{[4
]}

Lockshin, Michael ^{[1
]}

Branch, Ware ^{[5
]}

Laskin, Carl A. ^{[6
]}

Porter, T. Flint ^{[5
]}

Petri, Michelle ^{[7
]}

Merrill, Joan ^{[8
]}

Buyon, Jill P. ^{[9
]}

机构：

[1] Hosp Special Surg, New York, NY 10021 USA

[2] Albert Einstein Coll Med, Bronx, NY 10467 USA

[3] Brown Univ, Women & Infants Hosp Rhode Isl, Sch Med, Providence, RI 02912 USA

[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[5] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA

[6] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada

[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[8] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA

[9] NYU, Sch Med, New York, NY USA

来源：

ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4236 / 4236

页数：1

共 45 条

[31] Tissue pathway factor inhibitor (TFPI) activity is elevated in pregnant patients at 20 weeks gestation who subsequently develop preeclampsia
Hillman, Sarah
Chant, Ian
Gu, Mei
Rose, Peter
Vatish, Manu
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 778 - 780
[32] Anti-phosphorylcholine antibodies are protection factors for atherosclerosis and decreased in SLE patients both with and without CVD
Su, J.
Cederholm, A.
Svenungsson, E.
Hua, X.
Frostegard, J.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 360 - 360
[33] Elevated B-type natriuretic peptides predict resistant hypertension in patients with postpartum severe preeclampsia: a prospective cohort study
Annicchiarico, Walter
Vasquez, Angel
Santacruz, Jose
Villamizar, Leidy
Ramos-Classon, Enrique
Rojas-Suarez, Jose
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (12)
[34] Baseline Factors That Predict High BLyS Levels in Patients with Systemic Lupus Erythematosus (SLE) and High Disease Activity.
Roth, David
Thompson, April
Tang, Tom
Hammer, Anne
Molta, Charles T.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S723 - S724
[35] Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies
Kittiwan Choojitarom
Orawan Verasertniyom
Kitti Totemchokchyakarn
Kanokrat Nantiruj
Vasant Sumethkul
Suchela Janwityanujit
Clinical Rheumatology, 2008, 27 : 345 - 351
[36] Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies
Choojitarom, Kittiwan
Verasertniyom, Orawan
Totemchokchyakarn, Kitti
Nantiruj, Kanokrat
Sumethkul, Vasant
Janwityanujit, Suchela
CLINICAL RHEUMATOLOGY, 2008, 27 (03) : 345 - 351
[37] Prothrombotic change in inflammation-inducible coagulation factors identifies thrombotic risk in SLE patients with antiphospholipid antibodies.
Andersen, JC
Sagar, H
Syed, M
Haggood, AS
Patricia, D
BLOOD, 2003, 102 (11) : 120B - 120B
[38] FRAMINGHAM RISK FACTORS FAIL TO PREDICT CARDIOVASCULAR DISEASE IN SLE PATIENTS DURING A 10 YEAR FOLLOW-UP PERIOD
Bessant, R.
MacGregor, A.
Isenberg, D.
Hingorani, A.
Rahman, A.
RHEUMATOLOGY, 2003, 42 : 77 - 77
[39] Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome
von Tempelhoff, GF
Heilmann, L
Spanuth, E
Kunzmann, E
Hommel, G
THROMBOSIS RESEARCH, 2000, 100 (04) : 363 - 365
[40] Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort
Ugarte, Amaia
Garcia de Bustos, Alazne
Ruiz-Arruza, Ioana
Soto-Peleteiro, Adriana
Martin-Iglesias, Daniel
Gonzalez-Echavarri, Cristina
Ruiz-Irastorza, Guillermo
RHEUMATOLOGY, 2022, 61 (01) : 249 - 257

← 1 2 3 4 5 →